Trial Details
COMPLETEDBasic Information
| Clinical ID | c4581 |
|---|---|
| Identifier | NCT00295282 |
| Trial Title | A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: MDX-1100 (anti-CXCL10 human monoclonal antibody) |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2006-01 |
|---|---|
| Primary Completion Date | 2008-01 |
| Completion Date | 2008-01 |